Patent and Trademark Office issued a notice of allowance dealing with an invention that has numerous applications, including nucleic acid detection, quantification and purification, and determining genetic defects and mutations.
What does NOA stand for?
NOA stands for Notice of Allowance (US Patent and Trademark Office)
This definition appears frequently and is found in the following Acronym Finder categories:
- Military and Government
See other definitions of NOA
We have 84 other meanings of NOA in our Acronym Attic
- Nonobstructive Azoospermia
- Noroeste Argentino (Spanish: Argentine North West Region)
- North Atlantic Oscillation
- Northwest Orient Airlines
- Norwegians of America (gaming clan)
- Not Otherwise Authorized
- Notes on Anthropology (journal)
- Notice of Acceptance (Miami-Dade County Building Code Compliance Office)
- Notice of Action
- Notice of Adjustment
Samples in periodicals archive:
Littleton, CO; 303-794-2000) announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for a patent application, entitled "Method for Purifying FSH.
A third notice of allowance covers two chiral forms of the ISIS 2105 compound which will be useful in enhancing the drug properties of future generations of antisense compounds.
3 /PRNewswire/ -- DNA Plant Technology Corporation (Nasdaq: DNAP) announced that it has received notice of allowance from the European Patent Office for broad claims covering use of its Transwitch(TM) technology for any gene in any plant.
Amex: BPA) announced that a notice of allowance from the United States Patent & Trademark Office (USPTO) has been received covering the formulation used in Elestrin[TM] (estradiol gel), BioSante's newly approved treatment for menopausal women.
Patent Office has provided the company with a Notice of Allowance covering certain aspects of its SUPPLYSTATION system.
has received a Notice of Allowance from the United States Patent and Trademark Office for its Dual Path Immunoassay patent application publication #2006-0205059.
April 26 /PRNewswire/ -- Calgene (NASDAQ: CGNE) today announced several important developments in its genetically modified oils-related patent portfolio: the grant of a broad European patent for the company's work in seed-specific promoters, receipt of a Notice of Allowance from the U.